共 50 条
- [2] Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review FRONTIERS IN IMMUNOLOGY, 2022, 13
- [7] Dramatic exacerbation of bullous pemphigoid following rituximab and successful treatment with omalizumab European Journal of Dermatology, 2019, 29 : 213 - 215